Accession Number: | 0001415889-22-008163 |
Date: | 2022-08-01 |
Issuer: | HEALTHEQUITY, INC. (HQY) |
Original Submission Date: |
BLOOMBERG EDWARD
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100
DRAPER, UT 84020
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-08-01 | S | 1,000 | d | $57.63 | 59,850 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 82.39 | deemed execution date | 0 ( ) | 2028-08-13 | common stock 25,667 | $82.39 | 25,667 | direct | ||||
STOCK OPTION (RIGHT TO BUY) | 73.61 | deemed execution date | 0 ( ) | 2029-03-26 | common stock 22,367 | $73.61 | 22,367 | direct |
ID | footnote |
---|---|
f1 | the transactions reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 16, 2022. |
f2 | the option is exercisable as to 19,251 shares. the remaining 6,416 options become exercisable on august 13, 2022. |
f3 | the option is exercisable as to 16,776 shares. the remaining 5,591 options become exercisable on march 26, 2023. |